Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer

被引:61
作者
Aleskandarany, Mohammed A.
Sonbul, Sultan N.
Mukherjee, Abhik
Rakha, Emad A.
机构
[1] Univ Nottingham, Sch Med, Div Canc & Stem Cells, Nottingham, England
[2] Nottingham Univ Hosp NHS Trust, City Hosp Nottingham, Nottingham, England
关键词
Breast carcinoma; Epigenetics; Epithelial-mesenchymal transition; Extracellular matrix; Invasion; Lymphangiogenesis; Lymphovascular invasion; Migration; Tumorigenesis; BLOOD-VESSEL INVASION; PLEOMORPHIC LOBULAR CARCINOMA; VASCULAR INVASION; VASCULOGENIC MIMICRY; PODOPLANIN EXPRESSION; TUMOR-CELLS; ESTROGEN-RECEPTOR; PROGNOSTIC VALUE; E-CADHERIN; IN-VITRO;
D O I
10.1159/000433583
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Lymphovascular invasion (LVI), the presence of malignant cells within lymphovascular channels, is a crucial step in the invasion-metastasis cascade. LVI, when identified morphologically in the peritumoural area, is regarded as an indicator of metastatic potential and is strongly associated with a poor prognosis in many solid tumours, including breast cancer (BC). Although molecular mechanisms associated with the development of LVI have been extensively studied, details of driver genes, and molecular pathways and mechanisms involved in its development in BC, remain poorly defined. Although invasive BC cells have the ability to invade surrounding stroma, only those that can interact with endothelial cells, penetrate the vascular wall and withstand the intravascular stress will develop LVI and complete metastatic dissemination. Identification of additional molecular events associated with LVI in the primary tumour and characterisation of the contribution of the tumour micro-environment to modulating biological processes leading to LVI in BC remain a challenging task. This stems not only from the complexity of the molecular alterations in the primary tumour and the interactions with different components of its micro-environment but also from the subjective nature of LVI assessment in human BC. In this review, we discuss the clinicopathological features and the current knowledge of the molecular mechanisms underlying LVI in BC. (C) 2015 S. Karger AG, Basel
引用
收藏
页码:113 / 123
页数:11
相关论文
共 94 条
  • [1] Abe O, 2005, LANCET, V366, P2087, DOI 10.1016/s0140-6736(05)66544-0
  • [2] Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response
    Al-Kaabi, M. M.
    Alshareeda, A. T.
    Jerjees, D. A.
    Muftah, A. A.
    Green, A. R.
    Alsubhi, N. H.
    Nolan, C. C.
    Chan, S.
    Cornford, E.
    Madhusudan, S.
    Ellis, I. O.
    Rakha, E. A.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 112 (05) : 901 - 911
  • [3] Interaction of tumor cells and lymphatic vessels in cancer progression
    Alitalo, A.
    Detmar, M.
    [J]. ONCOGENE, 2012, 31 (42) : 4499 - 4508
  • [4] Molecular mechanisms of lymphangiogenesis in health and disease
    Alitalo, K
    Carmeliet, P
    [J]. CANCER CELL, 2002, 1 (03) : 219 - 227
  • [5] Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
    Alizadeh, Darya
    Trad, Malika
    Hanke, Neale T.
    Larmonier, Claire B.
    Janikashvili, Nona
    Bonnotte, Bernard
    Katsanis, Emmanuel
    Larmonier, Nicolas
    [J]. CANCER RESEARCH, 2014, 74 (01) : 104 - 118
  • [6] Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma
    Alpaugh, ML
    Tomlinson, JS
    Kasraeian, S
    Barsky, SH
    [J]. ONCOGENE, 2002, 21 (22) : 3631 - 3643
  • [7] SUMOylation proteins in breast cancer
    Alshareeda, Alaa T.
    Negm, Ola H.
    Green, Andrew R.
    Nolan, Christopher
    Tighe, Paddy
    Albarakati, Nada
    Sultana, Rebeka
    Madhusudan, Srinivasan
    Ellis, Ian O.
    Rakha, Emad A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2014, 144 (03) : 519 - 530
  • [8] Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer
    Alshareeda, Alaa T.
    Negm, Ola H.
    Albarakati, Nada
    Green, Andrew R.
    Nolan, Christopher
    Sultana, Rebeka
    Madhusudan, Srinivasan
    benHasouna, Ahmed
    Tighe, Paddy
    Ellis, Ian O.
    Rakha, Emad A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 301 - 310
  • [9] The tumor microenvironment at a glance
    Balkwill, Frances R.
    Capasso, Melania
    Hagemann, Thorsten
    [J]. JOURNAL OF CELL SCIENCE, 2012, 125 (23) : 5591 - 5596
  • [10] Bentz JS, 1998, MODERN PATHOL, V11, P814